March 19, 2024 12:30 PM ET

Online

This event will provide an overview of psychedelic treatments, including ibogaine and psilocybin, for substance use conditions. During this panel discussion, an ibogaine researcher, a certified recovery coach with lived experience, and a drug law expert will discuss existing research, potential benefits and risks, ongoing policy and legal reforms, and societal implications.

Panelists:

Moderator: Stephanie Tabashneck, PsyD, JD, Senior Fellow of Law and Applied Neuroscience, Center for Law Brain and Behavior at Harvard Medical School and Petrie-Flom Center; Licensed Psychologist; and Director, Brain InCite Neurolaw Library

Deborah Mash, Professor of Neurology and Molecular and Cellular Pharmacology, Leonard M. Miller School of Medicine; Director, Brain Endowment Bank at the University of Miami; and Chief Executive Officer and Founder, DemeRx

Mark Guckel, CCAR Recovery Coach Professional, EntheoRecovery Solutions, LLC

Mason Marks, MD, JD, Visiting Professor of Law, Harvard Law School; Senior Fellow and Project Lead of the Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center; and Florida Bar Health Law Section Professor, Florida State University College of Law